These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30961683)

  • 21. Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma.
    Haider A; Steininger A; Ullmann R; Hummel M; Dimitrova L; Beyer M; Vandersee S; Lenze D; Sterry W; Assaf C; Möbs M
    J Invest Dermatol; 2016 Nov; 136(11):2287-2296. PubMed ID: 27377697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol Enhances Chemosensitivity in Mouse Melanoma Model Through Connexin 43 Upregulation.
    Cheng YJ; Chang MY; Chang WW; Wang WK; Liu CF; Lin ST; Lee CH
    Environ Toxicol; 2015 Jul; 30(8):877-86. PubMed ID: 24449132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2].
    Han X; Tan ZJ; Guo RD; Li ZJ; Wang YL
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):17-21. PubMed ID: 23648294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
    Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile.
    Wang N; Zhang H; Cui X; Ma C; Wang L; Liu W
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression.
    Wu F; Cui L
    Arch Dermatol Res; 2017 Dec; 309(10):823-831. PubMed ID: 28936555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis.
    Shio S; Kodama Y; Ida H; Shiokawa M; Kitamura K; Hatano E; Uemoto S; Chiba T
    Cancer Sci; 2011 Apr; 102(4):776-83. PubMed ID: 21205092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells.
    Peng Z; Tang H; Wang X; Zhou C; Fan J; Wang L; Jia Z; Li Q; Le X; Wei D; Xie K
    Int J Oncol; 2008 Nov; 33(5):979-84. PubMed ID: 18949360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line.
    Wongpaiboonwattana W; Tosukhowong P; Dissayabutra T; Mutirangura A; Boonla C
    Asian Pac J Cancer Prev; 2013; 14(6):3773-8. PubMed ID: 23886181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
    Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
    Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between Runx3 gene expression and its DNA methylation in gastric cancer].
    Gao N; Chen WC; Cen JN
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):361-4. PubMed ID: 18953836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance and potential drug target of RUNX3 in breast cancer.
    Yu YY; Chen C; Kong FF; Zhang W
    Drug Des Devel Ther; 2014; 8():2423-30. PubMed ID: 25525332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
    Zhang S; Wei L; Zhang A; Zhang L; Yu H
    OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.
    Zhao S; Tang L; Chen W; Su J; Li F; Chen X; Wu L
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):797-807. PubMed ID: 33009925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
    Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
    Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between hypermethylation of Runx3 gene and the development and metastasis of laryngeal carcinoma].
    Tang J; Bai W; Ji W; Gao H; Liu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 24(18):834-7. PubMed ID: 21254652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Promoter methylation and expression of Runx3 gene in gastric cancer].
    Li LY; Li JK; Shen Y; Yu L; Zhang JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
    So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
    Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.